Twenty seven million adults in the United States are diagnosed as Diabetes Type 2. About half of the adults diagnosed with type 2 diabetes, who are not obese actually have Latent Autoimmune Diabetes according to a study presented by Dr. Shrivastav at the 21st annual meeting of the Society of Clinical Endocrinologists reported in an article in Medscape Medical News by Kate Johnson. The prevalence was higher among non-obese adults, with a shorter duration of the disease, younger age, a negative family history, sugars that are harder to control, and those with a more rapid onset of diabetic complications. Although auto-antibody testing for all diabetic patients is unrealistic, “a reasonable and cost-effective approach is to identify patients who have low insulin levels, and then do autoimmune testing on those individuals, regardless of age,” he said. He recommending testing with Antiglutamic acid decarboxylase (GAD) and islet cell autoantigen 512 (ICA512) antibody for people with low insulin levels. It is important to identify these patients because they need insulin therapy and in the future they may respond to the disease modifying techniques for Diabetes Type I that are currently being developed.
MEDICAL ADVICE DISCLAIMER: The information included on this site is for educational purposes only. It is not intended nor implied to be a substitute for professional medical advice. The reader should always consult his or her health care provider to determine the appropriateness of the information for their own situation, or if they have any questions regarding a medical condition or treatment plan. Reading the information on this website does not create a physician-patient relationship.